164 related articles for article (PubMed ID: 10889554)
21. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS
Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952
[TBL] [Abstract][Full Text] [Related]
22. Decreased hippocampal expression of the susceptibility gene PPP3CC and other calcineurin subunits in schizophrenia.
Eastwood SL; Burnet PW; Harrison PJ
Biol Psychiatry; 2005 Apr; 57(7):702-10. PubMed ID: 15820226
[TBL] [Abstract][Full Text] [Related]
23. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
[TBL] [Abstract][Full Text] [Related]
24. Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression.
Kristiansen LV; Meador-Woodruff JH
Schizophr Res; 2005 Oct; 78(1):87-93. PubMed ID: 16023328
[TBL] [Abstract][Full Text] [Related]
25. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium.
Knable MB; Barci BM; Webster MJ; Meador-Woodruff J; Torrey EF;
Mol Psychiatry; 2004 Jun; 9(6):609-20, 544. PubMed ID: 14708030
[TBL] [Abstract][Full Text] [Related]
26. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.
Guidotti A; Auta J; Davis JM; Di-Giorgi-Gerevini V; Dwivedi Y; Grayson DR; Impagnatiello F; Pandey G; Pesold C; Sharma R; Uzunov D; Costa E
Arch Gen Psychiatry; 2000 Nov; 57(11):1061-9. PubMed ID: 11074872
[TBL] [Abstract][Full Text] [Related]
27. Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia.
Fatemi SH; Earle JA; Stary JM; Lee S; Sedgewick J
Neuroreport; 2001 Oct; 12(15):3257-62. PubMed ID: 11711867
[TBL] [Abstract][Full Text] [Related]
28. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia.
Eastwood SL; McDonald B; Burnet PW; Beckwith JP; Kerwin RW; Harrison PJ
Brain Res Mol Brain Res; 1995 Apr; 29(2):211-23. PubMed ID: 7609609
[TBL] [Abstract][Full Text] [Related]
29. Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder.
Beneyto M; Meador-Woodruff JH
Neuropsychopharmacology; 2008 Aug; 33(9):2175-86. PubMed ID: 18033238
[TBL] [Abstract][Full Text] [Related]
30. Neuritic pathology is lacking in the entorhinal cortex, subiculum and hippocampus in middle-aged adults with schizophrenia, bipolar disorder or unipolar depression.
Damadzic R; Shuangshoti S; Giblen G; Herman MM
Acta Neuropathol; 2002 May; 103(5):488-94. PubMed ID: 11935265
[TBL] [Abstract][Full Text] [Related]
31. Striatal excitatory amino acid transporter transcript expression in schizophrenia, bipolar disorder, and major depressive disorder.
McCullumsmith RE; Meador-Woodruff JH
Neuropsychopharmacology; 2002 Mar; 26(3):368-75. PubMed ID: 11850151
[TBL] [Abstract][Full Text] [Related]
32. Dysregulation of glutamate carboxypeptidase II in psychiatric disease.
Guilarte TR; Hammoud DA; McGlothan JL; Caffo BS; Foss CA; Kozikowski AP; Pomper MG
Schizophr Res; 2008 Feb; 99(1-3):324-32. PubMed ID: 18191545
[TBL] [Abstract][Full Text] [Related]
33. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
[TBL] [Abstract][Full Text] [Related]
34. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
Kim S; Zavitsanou K; Gurguis G; Webster MJ
Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
[TBL] [Abstract][Full Text] [Related]
35. Medial temporal lobe structures and hippocampal subfields in psychotic disorders: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
Mathew I; Gardin TM; Tandon N; Eack S; Francis AN; Seidman LJ; Clementz B; Pearlson GD; Sweeney JA; Tamminga CA; Keshavan MS
JAMA Psychiatry; 2014 Jul; 71(7):769-77. PubMed ID: 24828364
[TBL] [Abstract][Full Text] [Related]
36. Synapsin II gene expression in the dorsolateral prefrontal cortex of brain specimens from patients with schizophrenia and bipolar disorder: effect of lifetime intake of antipsychotic drugs.
Tan ML; Dyck BA; Gabriele J; Daya RP; Thomas N; Sookram C; Basu D; Ferro MA; Chong VZ; Mishra RK
Pharmacogenomics J; 2014 Feb; 14(1):63-9. PubMed ID: 23529008
[TBL] [Abstract][Full Text] [Related]
37. Increased hippocampal supragranular Timm staining in subjects with bipolar disorder.
Dowlatshahi D; MacQueen G; Wang JF; Chen B; Young LT
Neuroreport; 2000 Nov; 11(17):3775-8. PubMed ID: 11117489
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
[TBL] [Abstract][Full Text] [Related]
39. Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
Vawter MP; Thatcher L; Usen N; Hyde TM; Kleinman JE; Freed WJ
Mol Psychiatry; 2002; 7(6):571-8. PubMed ID: 12140780
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder.
Thomsen MS; Weyn A; Mikkelsen JD
Bipolar Disord; 2011; 13(7-8):701-7. PubMed ID: 22085484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
